Clinical Trial Update: Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL [Phase 2]

View source ↗

Summary

Phase 2 study of the R-GemOx regimen (rituximab, gemcitabine, and oxaliplatin) evaluating efficacy and tolerance in diffuse large B-cell lymphoma and mantle cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• R-GemOx (rituximab, gemcitabine, oxaliplatin)
• Rituximab (rituximab)

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: Aggressive Lymphoma, Diffuse Large B-cell Lymphoma | Phase 2 | Status: COMPLETED